Merck Frosst Canada Inc. v. Canada ( Minister of Health )
T-1273-97
Dubé J.
2/7/97
5 pp.
Application for interim injunction directing respondent to revoke or suspend notice of compliance issued to Apotex Inc. for lovastatin-Irreparable harm to be established herein not irreparable harm to public or to patients involved, but irreparable harm to Merck-Interim injunction applied for merely ten-day injunction, not interlocutory injunction lasting up to trial of issue-Applicant Merck must show it will suffer irreparable harm during ten-day period-Not easy criteria to meet-Criteria not met-Threshold of serious issue very low-Threshold of irreparable harm very high-Injunction extraordinary remedy, discretionary-Application denied.
You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.